Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 129,558 | 153,225 | 91,028 | 110,747 | 134,730 |
| Receivables | 3,349 | 2,129 | 1,679 | 2,952 | N/A |
| Inventories | 1,495 | 1,316 | 1,576 | 1,214 | N/A |
| TOTAL | $136,466 | $158,575 | $95,369 | $116,450 | $135,551 |
| Non-Current Assets | |||||
| PPE Net | 1,007 | 1,038 | 772 | 676 | 695 |
| Intangibles | 1,973 | 2,103 | 2,273 | 2,500 | 0 |
| Other Non-Current Assets | 402 | 301 | 311 | 97 | 97 |
| TOTAL | $3,382 | $3,442 | $3,356 | $3,273 | $792 |
| Total Assets | $139,848 | $162,017 | $98,725 | $119,723 | $136,343 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,556 | 2,667 | N/A | 2,667 | 2,667 |
| Accounts payable and accrued liabilities | 6,793 | 9,106 | 8,970 | 6,074 | 6,189 |
| Accrued Expenses | 6,488 | 8,879 | 6,637 | 5,536 | 2,212 |
| TOTAL | $24,532 | $25,596 | $22,212 | $18,203 | $11,068 |
| Non-Current Liabilities | |||||
| Long Term Debt | 924 | 1,479 | 2,146 | 2,813 | 3,480 |
| Deferred Revenues | 8,695 | 4,944 | 6,605 | 3,926 | N/A |
| Other Non-Current Liabilities | 25 | 34 | 42 | 51 | 59 |
| TOTAL | $949 | $1,513 | $2,188 | $2,864 | $3,539 |
| Total Liabilities | $25,481 | $27,109 | $24,400 | $21,067 | $14,607 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,459 | 29,449 | 28,611 | 23,528 | 23,527 |
| Common Shares | 29 | 29 | 24 | 24 | 24 |
| Retained earnings | -246,262 | -223,184 | -195,625 | -169,180 | -144,661 |
| Other shareholders' equity | 0 | 0 | -3 | -3 | -3 |
| TOTAL | $114,367 | $134,908 | $74,325 | $98,656 | $121,736 |
| Total Liabilities And Equity | $139,848 | $162,017 | $98,725 | $119,723 | $136,343 |